Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion type Assertion NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_head.
- NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion description "[Our data suggest that IBTR risk after BCS in BRCA1/2 mutation carriers is increased compared with patients who have sporadic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_provenance.
- NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion evidence source_evidence_literature NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_provenance.
- NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion SIO_000772 19649554 NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_provenance.
- NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion wasDerivedFrom befree-20140225 NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_provenance.
- NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_assertion wasGeneratedBy ECO_0000203 NP694513.RAeaFxA1m3weyfdT8Bx9RvFTbeUxW6h-EsRiakkNqxAN4130_provenance.